NeuExcell Therapeutics Employee Directory
Biotechnology ResearchPennsylvania, United States2-10 Employees
NeuExcell Therapeutics is a biotechnology research company focused on gene therapy approaches for neurodegenerative diseases. The organization aims to regenerate neurons in the brain with the goal of improving outcomes for patients facing serious neurological conditions. Its stated disease areas include stroke, Huntington's disease, ALS, and traumatic brain injury. It is based in King of Prussia, Pennsylvania, and described as a small team in the biotech sector. The company positions itself within the biotechnology field as pursuing strategies to restore damaged neural tissue through gene therapy. In May 2026, NeuExcell announced that the first-in-human study of NXL-004 for recurrent malignant glioma will be presented at the ASCO 2026 meeting.